(Q24247368)

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Baseline characteristics in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Quality assurance and monitoring in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Hypertension treated by salt restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Feasibility and efficacy of sodium reduction in the Trials of Hypertension Prevention, phase I. Trials of Hypertension Prevention Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Lack of blood pressure effect with calcium and magnesium supplementation in adults with high-normal blood pressure. Results from Phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Recruitment for phase II of the Trials of Hypertension Prevention. Effective strategies and predictors of randomization. Trials of Hypertension Prevention (TOHP) Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Trials of Hypertension Prevention, phase II. Structure and content of the weight loss and dietary sodium reduction interventions. Trials of Hypertension Prevention (TOHP) Collaborative Research Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Antihypertensive effect of diet compared with drug treatment in obese men with mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Double-blind randomised trial of modest salt restriction in older people.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effects of dietary patterns on blood pressure: subgroup analysis of the Dietary Approaches to Stop Hypertension (DASH) randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary treatment of hypertension. II. Sodium depletion as related to the therapeutic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Nonpharmacologic therapy of hypertension: the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Re-analysis of data in two Lancet papers on the effect of dietary sodium and potassium on blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Responses of atrial natriuretic factor to long-term sodium restriction in mild to moderate hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Response of diastolic blood pressure to long-term sodium restriction is posture related

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Adherence to the salt restriction diet among people with mildly elevated blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Evaluation of a structured treatment and teaching programme on hypertension in general practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

THE RELATIONSHIP OF SODIUM CHLORIDE TO HYPERTENSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Primary prevention of hypertension by nutritional-hygienic means. Final report of a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effect of antihypertensive therapy on weight loss. The Trial of Antihypertensive Interventions and Management Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Trial of antihypertensive intervention and management: greater efficacy with weight reduction than with a sodium-potassium intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary sodium restriction as adjunctive treatment of hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary approaches to the reduction of blood pressure: the independence of weight and sodium/potassium interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary calcium and blood pressure: a meta-analysis of randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dieting to reduce body weight for controlling hypertension in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

An empirical study of cluster randomization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Lowering blood pressure: a systematic review of sustained effects of non-pharmacological interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Intersalt revisited: further analyses of 24 hour sodium excretion and blood pressure within and across populations. Intersalt Cooperative Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

The influence of dietary and nondietary calcium supplementation on blood pressure: an updated metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Reduced or modified dietary fat for prevention of cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Early sodium intake and later blood pressure in preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Salt--overwhelming evidence but still no action: can a consensus be reached with the food industry? CASH (Consensus Action on Salt and Hypertension)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

The kidney in blood pressure regulation and development of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

British Hypertension Society guidelines for hypertension management 1999: summary

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Guidelines for management of hypertension: report of the third working party of the British Hypertension Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Cost and health consequences of reducing the population intake of salt

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Comparison of the prediction by 27 different factors of coronary heart disease and death in men and women of the Scottish Heart Health Study: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Systematic review of long term effects of advice to reduce dietary salt in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Salt restriction in hypertensive patients. Comparison of advice, education, and group management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effects of Sodium Restriction on Blood Pressure, Renin, Aldosterone, Catecholamines, Cholesterols, and Triglyceride

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

A random-effects regression model for meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Low-sodium diet versus low-sodium/high-potassium diet for treatment of hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Moderate sodium restriction and diuretics in the treatment of hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Background and design of the new U.S. trial on diet and drug treatment of "mild" hypertension (TOMHS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Nonpharmacological control of hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Lack of impact of salt restriction advice on hypertensive patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Design, methods, and rationale in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Treatment in the Hypertension Prevention Trial. Hypertension Prevention Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Demographic, knowledge, physiological, and behavioral variables as predictors of compliance with dietary treatment goals in hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Variance imputation for overviews of clinical trials with continuous response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Trials of hypertension prevention. Phase I design.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Differences in precision of dietary estimates among different population subgroups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Design of a multicenter trial to evaluate long-term life-style intervention in adults with high-normal blood pressure levels. Trials of Hypertension Prevention (phase II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Baseline characteristics of participants in phase II of the Trials of Hypertension Prevention (TOHP II). Trials of Hypertension Prevention (TOHP) Collaborative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Does withdrawal of antihypertensive medication increase the risk of cardiovascular events? Trial of Nonpharmacologic Interventions in the Elderly (TONE) Cooperative Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Early nutrition in preterm infants and later blood pressure: two cohorts after randomised trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Neonatal salt intake and blood pressure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Salt restriction and no drug treatment in mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Evaluation of the effectiveness of a low sodium diet in the treatment of mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Attributions for dietary failures: problems reported by participants in the Hypertension Prevention Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effects of a low-salt diet and of acute salt loading on blood pressure and intralymphocytic sodium concentration in young subjects with borderline hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The role of salt in the fall of blood pressure accompanying reduction in obesity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Hypertension prevention trial: do 24-h food records capture usual eating behavior in a dietary change study?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Randomized trials of sodium reduction: an overview

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The Trial of Antihypertensive Interventions and Management (TAIM) Study. Final results with regard to blood pressure, cardiovascular risk, and quality of life

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Lack of effectiveness of a low-sodium/high-potassium diet in reducing antihypertensive medication requirements in overweight persons with mild hypertension. TAIM Research Group. Trial of Antihypertensive Interventions and Management

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Dietary NaCl restriction deteriorates oral glucose tolerance in hypertensive patients with impairment of glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effect of change in sodium excretion on change in blood pressure corrected for measurement error. The Trials of Hypertension Prevention, Phase I

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Does potassium supplementation lower blood pressure? A meta-analysis of published trials

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Enhanced blood pressure response to dietary salt in elderly women, especially those with small waist: hip ratio

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Treatment of hypertension in obese patients: efficacy and feasibility of weight and salt reduction programs.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Addition of non-pharmacological methods of treatment in patients on antihypertensive drugs: results of previous medication, laboratory tests and life quality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Long-term nopharmacological treatment for mild to moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

CHANGE IN BLOOD PRESSURE IN RELATION TO CHANGE IN NUTRIENTS EFFECTED BY MANIPULATION OF DIETARY SODIUM AND POTASSIUM

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The (political) science of salt

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Dietary sodium restriction for mild hypertension in general practice

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Blood pressure control during weight reduction in obese hypertensive men: separate effects of sodium and energy restriction.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Beta blockade, diuretics, and salt restriction for the management of mild hypertension: a randomised double blind trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Plasma atrial natriuretic peptide in essential hypertension: effects of changes in dietary sodium

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Sodium manipulation in the management of hypertension. The view against its general use

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Sodium restriction can delay the return of hypertension in patients previously well-controlled on drug therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Interaction of enalapril with sodium restriction, diuretics, and slow-channel calcium-blocking drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Controlled observations on the effect of low sodium dietotherapy in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild-to-moderate essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Effect of drug and diet treatment of mild hypertension on diastolic blood pressure. The TAIM Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Reduction of salt intake during converting enzyme inhibitor treatment compared with addition of a thiazide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Unchanged central hemodynamics after six months of moderate sodium restriction with or without potassium supplement in essential hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Diet and exercise intervention have favourable effects on blood pressure in mild hypertensives: the Oslo Diet and Exercise Study (ODES)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

The antihypertensive effect of verapamil at extremes of dietary sodium intake

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003656.PUB2

7 January 2021

10.1002/14651858.CD003656.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

869670

869670

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference